BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3024645)

  • 1. Dual effects of a new hypocalcemic agent, WR-2721, on cytoplasmic Ca2+ and parathyroid hormone release of dispersed parathyroid cells from patients with hyperparathyroidism.
    Larsson R; Nygren P; Wallfelt C; Akerström G; Rastad J; Ljunghall S; Gylfe E
    Biochem Pharmacol; 1986 Dec; 35(23):4237-41. PubMed ID: 3024645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical effects of K+ and D-600 on parathyroid hormone secretion and cytoplasmic Ca2+ in normal bovine and pathological human parathyroid cells.
    Larsson R; Akerström G; Gylfe E; Johansson H; Ljunghall S; Rastad J; Wallfelt C
    Biochim Biophys Acta; 1985 Nov; 847(2):263-9. PubMed ID: 4063399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of parathyroid hormone secretion and parathyroid hormone-independent diminution of tubular calcium reabsorption by WR-2721, a unique hypocalcemic agent.
    Hirschel-Scholz S; Caverzasio J; Bonjour JP
    J Clin Invest; 1985 Nov; 76(5):1851-6. PubMed ID: 2997292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalizing effect of Ca2+ ionophore on cytoplasmic Ca2+ and parathyroid hormone release of dispersed parathyroid cells from patients with hyperparathyroidism.
    Larsson R; Wallfelt C; Akerström G; Ljunghall S; Rastad J; Gylfe E
    Mol Cell Endocrinol; 1986 May; 45(2-3):191-6. PubMed ID: 3086157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between external and cytoplasmic calcium concentrations, parathyroid hormone release and weight of parathyroid glands in human hyperparathyroidism.
    Wallfelt C; Gylfe E; Larsson R; Ljunghall S; Rastad J; Akerström G
    J Endocrinol; 1988 Mar; 116(3):457-64. PubMed ID: 3351432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperparathyroidism is associated with reduced expression of a parathyroid calcium receptor mechanism defined by monoclonal antiparathyroid antibodies.
    Juhlin C; Klareskog L; Nygren P; Ljunghall S; Gylfe E; Rastad J; Akerström G
    Endocrinology; 1988 Jun; 122(6):2999-3001. PubMed ID: 2836180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone and parathyroid inhibitory effects of S-2(3-aminopropylamino)ethylphosphorothioic acid. Studies in experimental animals and cultured bone cells.
    Attie MF; Fallon MD; Spar B; Wolf JS; Slatopolsky E; Goldfarb S
    J Clin Invest; 1985 Apr; 75(4):1191-7. PubMed ID: 2985652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective regulation of the cytosolic Ca2+ activity in parathyroid cells from patients with hyperparathyroidism.
    Larsson R; Wallfelt C; Abrahamsson H; Gylfe E; Ljunghall S; Rastad J; Rorsman P; Wide L; Akerström G
    Biosci Rep; 1984 Nov; 4(11):909-15. PubMed ID: 6525449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the antihypercalcemic drugs gallium nitrate and pamidronate on hormone release of pathologic human parathyroid cells.
    Ridefelt P; Gylfe E; Akerström G; Rastad J
    Surgery; 1995 Jan; 117(1):56-61. PubMed ID: 7809837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimethyl sulfoxide increases cytoplasmic Ca2+ concentration and inhibits parathyroid hormone release in normal bovine and pathological human parathyroid cells.
    Nygren P; Larsson R; Rastad J; Akerström G; Gylfe E
    Biochim Biophys Acta; 1987 Apr; 928(2):194-8. PubMed ID: 3567228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of the hypocalcemic agent WR-2721 and its acute and chronic application in eu- and hyperparathyroidism.
    Hirschel-Scholz S; Caverzasio J; Bonjour JP
    Adv Exp Med Biol; 1986; 208():367-70. PubMed ID: 3031946
    [No Abstract]   [Full Text] [Related]  

  • 12. Parathyroid tissue in normocalcemic and hypercalcemic primary hyperparathyroidism recruited by health screening.
    Lundgren E; Ridefelt P; Akerström G; Ljunghall S; Rastad J
    World J Surg; 1996 Sep; 20(7):727-34; discussion 735. PubMed ID: 8678973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ga3+ inhibits parathyroid hormone release without interacting with the Ca2+ receptor of the parathyroid cell.
    Ridefelt P; Hellman P; Ljunggren O; Ljunghall S; Akerström G; Rastad J; Gylfe E
    Biochem Biophys Res Commun; 1992 Jul; 186(1):556-61. PubMed ID: 1321615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between parathyroid hormone secretion and cytosolic calcium concentration in dispersed bovine parathyroid cells.
    Shoback DM; Thatcher J; Leombruno R; Brown EM
    Proc Natl Acad Sci U S A; 1984 May; 81(10):3113-7. PubMed ID: 6328497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic evidence for cytoplasmic calcium as an inhibitory messenger in parathyroid hormone release.
    Wallfelt C; Lindh E; Larsson R; Johansson H; Rastad J; Akerström G; Gylfe E
    Biochim Biophys Acta; 1988 May; 969(3):257-62. PubMed ID: 3370224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulating parathyroid cell proliferation and PTH release with phosphate in organ cultures obtained from patients with primary and secondary hyperparathyroidism for a prolonged period.
    Nakajima K; Umino K; Azuma Y; Kosaka S; Takano K; Obara T; Sato K
    J Bone Miner Metab; 2009; 27(2):224-33. PubMed ID: 19194773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of parathyroid hormone-dependent nephrocalcinosis by chronic administration of the organic phosphorothioate WR-2721.
    Hirschel-Scholz S; Caverzasio J; Bonjour JP
    Calcif Tissue Int; 1987 Feb; 40(2):103-8. PubMed ID: 3032378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoride interactions with stimulus-secretion coupling of normal and pathological parathyroid cells.
    Ridefelt P; Hellman P; Rastad J; Larsson R; Akerström G; Gylfe E
    Acta Physiol Scand; 1992 Jul; 145(3):275-85. PubMed ID: 1325732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microfluorometric measurements of cytoplasmic calcium in chief and oxyphil parathyroid cells of adenomatous and hyperplastic glands and of normal-sized glands associated with adenomas.
    Johansson H; Rastad J; Bjerneroth G; Gylfe E; Akerström G
    Surgery; 1989 Sep; 106(3):517-24. PubMed ID: 2772827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of parathyroid secretion after administration of WR-2721 in a patient with parathyroid carcinoma.
    Hirschel-Scholz S; Jung A; Fischer JA; Trechsel U; Bonjour JP
    Clin Endocrinol (Oxf); 1985 Sep; 23(3):313-8. PubMed ID: 3000652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.